NORWICH, UK – 07 September 2021: Leaf Expression Systems (Leaf), a biotechnology company specialising in plant-based expression, today announced the launch of SupraVecTM, Leaf’s new proprietary vector-based expression technology for the rapid production of proteins, vaccines and complex biomolecules within the leaf tissue of plants.
SupraVecTM is a plant transient expression system designed with novel expression components to optimise yields. The expression technology delivers a three-fold improvement in the yield compared to Leaf’s previous pEAQ-HT system, also known as Hypertrans® (figure 1). The increased yield achieved by SupraVecTM will enable viable expression of a larger number of products and reduce the cost of goods for Leaf’s clients.
Simon Saxby, CEO: “The launch of SupraVecTM, our new proprietary expression technology, is a significant milestone for Leaf and greatly enhances the options we can offer our clients for expression and scale-up manufacture of their biologics. SupraVecTM is the result of excellent work by the Leaf team, led by Dr Nick Holton and Dr Albor Dobon-Alonso, and I am delighted that their efforts have led to this impressive and valuable achievement.”
Nick Holton, Principal Scientist – R&D “We are striving to obtain the highest possible protein yields, and the development of the SupraVecTM technology greatly enhances the level of protein that we can obtain during plant transient expression. This technology is a significant leap forward and will improve protein yields and the economics of plant transient expression.”
About Leaf Expression Systems
Leaf Expression Systems is a contract development and manufacturing business specialising in plant-based expression and production of proteins, vaccines and complex natural products for research and commercial applications.
Its vector technologies allow for the rapid simultaneous production of multiple gene products in a controlled and coordinated manner within the tissues of plants. Using gene synthesis and modular vectors, new products such as vaccines, antibodies or enzymes can be produced at speed and on a large scale, so it is well suited to be able to rapidly respond to emergencies like pandemics.
LinkedIn: @Leaf Expression Systems
For further information, contact:
For Leaf Expression Systems
Polly Ferris, Marketing & Communications Office
T: +44 (0) 1603 859 298